Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Syndax Pharmaceuticals Inc (SNDX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross profit | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | | 81.2% | 4808.2% | | | | | |
| Research and development | | | | 2834.1% | 3962.2% | 2286.6% | 2595.5% | 1523.0% |
| General and administrative | | | | 1058.8% | 1139.6% | 752.4% | 1091.9% | 1848.6% |
| Depreciation | | | | 6.1% | 5.1% | 3.6% | 7.3% | 3.3% |
| EBIT | | 17.8% | -4822.5% | -3792.9% | -5001.7% | -2939.0% | -3587.4% | -3271.6% |
| Pre-tax income | | 17.8% | -4822.5% | -3694.6% | -4875.5% | -2884.3% | -3645.2% | -3846.7% |
| Income taxes | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | | 17.8% | -4822.5% | -3694.6% | -4875.5% | -2884.3% | -3858.2% | -16562.2% |
|